Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Maria Argento
Observed names:
Argento, Chiara Maria,
C M Argento,
C.M. Argento,
Chiara Argento,
Chiara M. Argento
Institutions:
Istituto delle Scienze Neurologiche di Bologna,
Ospedale Bellaria
Observed institutions:
University of Trento,
Azienda USL di Bologna,
Institute of Neurological Sciences,
Istituto delle Scienze Neurologiche di Bologna,
Ospedale Bellaria,
University of Bologna
show all 6
ORCID:
0000-0001-8419-7311
Observed ORCID:
0000-0001-8419-7311
OpenAlex ID:
A5028700425
Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel
2020
·
Dario de Biase
, Giorgia Acquaviva
, et al.
·
Diagnostics
·
77
PDF
BRAF Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development
2020
·
Giorgia Acquaviva
, Dario de Biase
, et al.
·
Cancers
·
11
PDF
Concordance Between RTOG and EORTC Prognostic Criteria in Low-Grade Gliomas
2019
·
Enrico Franceschi
, Antonella Mura
, et al.
·
Future Oncology
·
8
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study
2020
·
Sirio Fiorino
, Michela Visani
, et al.
·
Molecular Biology Reports
·
7
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review
2026
·
Giovanni Dima
, Vincenzo Di Nunno
, et al.
·
Frontiers in Oncology
·
5
PDF
Cutting-edge approaches in pet imaging for gliomas: current applications for neurooncologists and the path to theranostic breakthroughs
2026
·
Lidia Gatto
, Riccardo Mei
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
3
The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
2025
·
Alicia Tosoni
, Vincenzo Di Nunno
, et al.
·
Oral Oncology
·
3
Survival outcomes in glioma patients with noncanonical IDH mutations: Beyond diagnostic improvements.
2019
·
Enrico Franceschi
, Dario De Biase
, et al.
·
Journal of Clinical Oncology
·
2
Advances in the Optimization of CAR-T-Cell-Based Therapeutic Approaches to Enhance Antitumor Efficacy in Glioblastoma Treatment
2025
·
Lidia Gatto
, Vincenzo Di Nunno
, et al.
·
Oncology and Therapy
·
1
PDF
Brain tumor susceptibility: From genetic predisposition syndromes to extended characterization of genomic determinants
2026
·
Marta Aprile
, Vanessa Callegari
, et al.
·
Critical Reviews in Oncology/Hematology
Caregiver professional employment and its impact on glioblastoma patient survival: Results from two prospective studies.
2026
·
Vincenzo Di Nunno
, Alicia Tosoni
, et al.
·
Journal of Clinical Oncology
PDF
Ultrasound-Based Therapies in Primary Central Nervous System Tumors
2026
·
Giovanni Dima
, Alessandro Olivari
, et al.
·
Cancers
PDF
Financial toxicity, Socioeconomic Status, and clinical outcome in Glioblastoma: the ISES-2 Prospective Multicenter Italian Study
2026
·
Alicia Tosoni
, Laura Arenare
, et al.
·
SSRN Electronic Journal
How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysis
2025
·
Marta Aprile
, Vincenzo Di Nunno
, et al.
·
Frontiers in Oncology
PDF
Unveiling Oligodendrocyte-Lineage Differentiation in the Glioblastoma Infiltrative Zone Through Spatial Transcriptomics
2025
·
Chiara Maria Argento
, Enrico Sebastiani
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
WITHDRAWN: 1455eP the role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis
2025
·
V. Di Nunno
, A. Carlini
, et al.
·
Annals of Oncology
Emerging strategies and advances in the management of sinonasal carcinoma
2025
·
Alicia Tosoni
, Maria Pia Foschini
, et al.
·
Expert Review of Anticancer Therapy
P02.02.b Loss of Elavl2 Promotes Maintenance and Tumorigenic Competence in Glioblastoma
2023
·
C M Argento
, A Modelska
, et al.
·
Neuro-Oncology
PDF
IDH1 polymorphism G105G (rs11554137) as a prognostic factor in gliomas.
2019
·
Enrico Franceschi
, Dario De Biase
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
117
H-index:
5
I10-index:
2
Year
Topic
Type